Hongcheng Liu

Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

Xinsheng Zhu, Liangdong Sun, Nan Song et al. · BMC Medicine · 2022 · 64 citations · Full text

A Clinical Risk Model for the Evaluation of Bronchopleural Fistula in Non-Small Cell Lung Cancer After Pneumonectomy

Xuefei Hu, Liang Duan, Gening Jiang et al. · The Annals of Thoracic Surgery · 2013 · 62 citations

Surgical Oncology, Clinical Risk Model, Pneumothorax +9

[Shanghai Pulmonary Hospital Experts Consensus on the Management of Ground-Glass Nodules Suspected as Lung Adenocarcinoma (Version 1)].

Gening Jiang, Chang Chen, Yuming Zhu et al. · PubMed · 2018 · 46 citations · Full text

The expression of heparanase and microRNA-1258 in human non-small cell lung cancer

Hongcheng Liu, Xiaofeng Chen, Wen Gao et al. · Tumor Biology · 2012 · 34 citations

Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation

Fengqing Hu, Hongcheng Liu, Xiao Xie et al. · Molecular Carcinogenesis · 2015 · 31 citations · Full text